Concepedia

Lars Grönke

LG

Statistics

Publications

19

Citations

1.4K

H-Index

17

Active since

1997

Affiliations

Boehringer Ingelheim (Germany)(Current)

LungenClinic Grosshansdorf

Boehringer Ingelheim (United States)

Pulmonary Associates

Lund University

Lars Grönke is an author at Boehringer Ingelheim (Germany) specializing in chronic obstructive pulmonary disease, pulmonology, and pharmacotherapy.

Publications per year

1997–2020

19

Publications

19

Tiotropium and olodaterol fixed-dose combination <i>versus</i> mono-components in COPD (GOLD 2–4)

Roland Buhl, François Maltais, R Abrahams et al. · European Respiratory Journal · 2015 · 322 citations · Full text

, , +17

Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial

Peter M.A. Calverley, Antonio Anzueto, Kerstine Carter et al. · The Lancet Respiratory Medicine · 2018 · 198 citations · Full text

, , +9

Tiotropium + olodaterol shows clinically meaningful improvements in quality of life

Dave Singh, Gary T. Ferguson, J Bolitschek et al. · Respiratory Medicine · 2015 · 175 citations · Full text

, , +17

The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease

Kai-Michael Beeh, Jan Westerman, Anne‐Marie Kirsten et al. · Pulmonary Pharmacology & Therapeutics · 2015 · 113 citations · Full text

, , +17

The lung function profile of once-daily tiotropium and olodaterol via Respimat&amp;reg; is superior to that of twice-daily salmeterol and luticasone propionate via&amp;nbsp;Accuhaler&amp;reg; (ENERGITO&amp;reg; study)

Kai Michael Beeh, Eric Derom, José Echave-Sustaeta et al. · International Journal of COPD · 2016 · 106 citations · Full text

, , +16

1–5 of 19